Status:
WITHDRAWN
Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This research studies protein in tumor samples from patients with non-small cell lung cancer. Finding specific proteins in tumor tissue samples from patients with cancer may help doctors tell what typ...
Detailed Description
PRIMARY OBJECTIVES: I. To validate a novel 4-protein signature's ability to subtype non-small cell lung cancer (NSCLC) in a treatment-naive, multi-institutional cohort, Cancer and Leukemia Group B (C...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients must have been registered on CALGB-9761
- Stage I disease
- Treatment-naive patients
- A representative paraffin block of the primary tumor must be available from patients on CALGB-9761 and submitted to the CALGB Pathology Coordinating Office
- A separate consent form is not required for this study, as permission for research to be performed on the tissue blocks is included in the consent form for CALGB 9761
- Institutional review board (IRB) review and approval at the institution where the laboratory work will be performed is required
Exclusion
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01415739
Start Date
October 1 2011
End Date
August 1 2015
Last Update
January 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alliance for Clinical Trials in Oncology
Boston, Massachusetts, United States, 02115